ADMA Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-28.24	-65.9	-71.65	-75.75	-48.28	-65.74	-43.76	-19.52	-17.97	-16.81	Upgrade
Depreciation & Amortization	8.33	7.11	5.5	3.94	3.26	3.45	2.69	0.47	0.47	0.25	Upgrade
Share-Based Compensation	6.19	5.22	3.49	2.86	2.65	2.22	1.56	1.25	1.71	1.25	Upgrade
Other Operating Activities	22.52	-5.93	-49.71	-33.05	-33.82	-2.6	2.23	-0.47	0.37	0.61	Upgrade
Operating Cash Flow	8.8	-59.51	-112.37	-102	-76.19	-62.68	-37.27	-18.27	-15.42	-14.7	Upgrade
Capital Expenditures	-4.77	-13.91	-13.51	-12.72	-3.81	-2.1	-2.68	-0.07	-0.03	-2.32	Upgrade
Acquisitions	0	0	0	0	0	0	12.5	0	0	0	Upgrade
Change in Investments	0	0	0	0	0	0	5.39	0.98	-1.72	-1.72	Upgrade
Other Investing Activities	-0.21	-	-	-	-	-	-	-	-	-	Upgrade
Investing Cash Flow	-4.98	-13.91	-13.51	-12.72	-3.81	-2.1	15.21	0.9	-1.74	-4.04	Upgrade
Share Issuance / Repurchase	1.1	64.82	121.14	131.21	48.47	42.96	39.21	12.9	10.31	0	Upgrade
Debt Issued / Paid	-25.19	51.71	-0.03	13.52	38.03	-0.04	21.54	3.94	0.1	9.81	Upgrade
Other Financing Activities	-14.91	-7.68	-0.06	-0.83	-6.5	-	-	-	-	-0.01	Upgrade
Financing Cash Flow	-38.99	108.85	121.05	143.9	80	42.92	60.75	16.84	10.4	9.8	Upgrade
Net Cash Flow	-35.17	35.43	-4.83	29.17	-0	-21.85	38.69	-0.53	-6.76	-8.95	Upgrade
Free Cash Flow	4.03	-73.42	-125.88	-114.73	-80.01	-64.77	-39.95	-18.34	-15.44	-17.03	Upgrade
Free Cash Flow Margin	1.56%	-47.65%	-155.52%	-271.74%	-272.60%	-381.36%	-175.51%	-172.05%	-215.18%	-287.85%	Upgrade
Free Cash Flow Per Share	0.02	-0.37	-0.90	-1.33	-1.47	-1.43	-1.75	-1.51	-1.48	-1.83	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).